From: Longitudinal study of leptin levels in chronic hemodialysis patients
 | 95% confidence interval | |||||
---|---|---|---|---|---|---|
 | Estimate | Lower | Upper | F | P | Pa |
Dietary intake | Â | Â | Â | Â | Â | Â |
Δ DEI (kcal/kg/d) | -0.2285 | -0.7376 | 0.2699 | 0.914 | 0.32 | 0.46 |
Δ DPI (g/kg/d) | -0.0119 | -0.0334 | 0.0134 | 1.087 | 0.30 | 0.86 |
Δ nPNA | 0.0020 | -0.1572 | 0.0197 | 0.049 | 0.83 | 0.47 |
Biochemical markers | Â | Â | Â | Â | Â | Â |
Δ Albumin (g/L) | -0.2665 | -0.4403 | 0.0928 | 2.371 | 0.13 | 0.37 |
Δ Transferrin (mg/dL) | -1.6025 | -3.4108 | 0.2059 | 3.111 | 0.08 | 0.81 |
Δ Creatinine (mg/dL) | -0.0261 | -0.1158 | 0.0635 | 0.336 | 0.56 | 0.52 |
Δ Cholesterol (mg/dL) | -2.9192 | -4.8957 | 0.9428 | 1.676 | 0.24 | 0.32 |
Δ IL-6 (mcg/ml) | 2.8850 | -1.8151 | 3.9548 | 0.971 | 0.34 | 0.46 |
EPO dose (x10 2 u/kg/w) | 5.9104 | -1.6371 | 13.4579 | 2.429 | 0.12 | 0.90 |
Anthropometric measurements | Â | Â | Â | Â | Â | Â |
Δ BMI (kg/m 2 ) b | -0.1259 | -0.2389 | -0.0129 | 5.011 | 0.030 | 0.57 |
Δ TSF (mm) | -0.4376 | -0.7181 | -0.1571 | 10.100 | 0.003 | 0.09 |
ΔMAC (cm) | 0.0409 | -0.0945 | 0.1764 | 0.374 | 0.55 | 0.26 |
ΔMAMC (cm) | -0.2066 | -0.3356 | -0.0777 | 10.550 | 0.002 | 0.20 |
Bioimpedance analysis | Â | Â | Â | Â | Â | Â |
Δ FMI (kg/m 2 ) b | -0.1467 | -0.2697 | -0.0211 | 5.512 | 0.021 | 0.76 |
Δ FFMI (kg/m 2 ) | -0.1459 | -0.2044 | -0.0874 | 24.760 | < 0.001 | 0.15 |
Δ Phase angle (°) | -0.1018 | -0.1377 | -0.0659 | 31.898 | < 0.001 | 0.38 |